Continuous glucose monitoring (CGM) for four days.

DEVICE2 trials

Sponsors

Rigshospitalet, Denmark

Conditions

Chronic Kidney DiseasesKidney TransplantNon-Alcoholic Fatty Liver DiseasePreDiabetesType2 Diabetes

Unknown Phase

NAFLD Among Patients With Type 2 Diabetes and CKD

CompletedNCT03826381

Rigshospitalet, DenmarkChronic Kidney Diseases, Non-Alcoholic Fatty Liver Disease, Type2 Diabetes

Start: 2019-05-06End: 2021-06-23Updated: 2021-09-01

NAFLD Among Patients With Chronic Kidney Disease and the Effect of Kidney Transplantation

TerminatedNCT03866421

Rigshospitalet, DenmarkChronic Kidney Diseases, Kidney Transplant, Non-Alcoholic Fatty Liver Disease +1

Start: 2019-05-29End: 2022-03-31Updated: 2022-05-02